MedTrace Logo

Retrospective Comparative in Vitro Case-controlled Study of the Liquid Biopsy Test System in Women With Breast Cancer

NCT04927130 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2021-06-25

No results posted yet for this study

Summary

Proof of Concept retrospective study. Women who have the diagnosis Breast Cancer ( confirmed by biopsy) will donate a blood samples. Tubes with blood will be transferred to the Sponsors Laboratory and ARNA Breast Test will be performed. The result of test will be compared with the biopsy result for each person.

Conditions

  • Breast Neoplasm Female

Interventions

DIAGNOSTIC_TEST

ARNA Breast

A specific DNA fragments and globulins will be detected in blood plasma.

Sponsors & Collaborators

  • BIOMARKER-RU

    collaborator UNKNOWN

  • ARNA Genomics US Inc.

    lead INDUSTRY

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-16
Primary Completion
2021-10-29
Completion
2021-12-31

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04927130 on ClinicalTrials.gov